Back to top

WELCOME TO ZACKS.COM

Zacks' 7 Strongest Buys for June, 2024

Our experts just released their predictions for 7 stocks likely to climb the highest in the next 30-90 days. Hand-picked from 220 new Strong Buys, these "best of the best" stocks are spring-loaded and ready to soar. Recent picks have climbed as much as +67.5% within 30 days.

WELCOME TO ZACKS.COM

Zacks' 7 Strongest Buys for June, 2024

Our experts just released their predictions for 7 stocks likely to climb the highest in the next 30-90 days. Hand-picked from 220 new Strong Buys, these "best of the best" stocks are spring-loaded and ready to soar. Today's dip gives you a chance to snag these stocks at attractive prices. Recent picks have climbed as much as +67.5% within 30 days.

No cost. No credit card. No obligation to buy anything ever. Past performance is no guarantee of future results.
We respect your privacy. Zacks Ultimate Member? Click here.

Why Stocks Are On Pace For A Historic Bull Market This Year

Don't let the old and outdated adage "Sell in May and Go Away" keep you from taking advantage of this bull market. Now that stocks have full recovered from their April pullback, Kevin explains how you can profit from what's shaping up to be a bull run for the ages.

loading...

Free Book: Finding #1 Stocks

Top stock-picking secrets and strategies to help beat the market.

Top stock-picking secrets and strategies to help beat the market.

Retail Earnings: A Closer Look

The bulk of the Q1 earnings season is now behind us, with results from more than 460 S&P 500 companies already out. This week, retail took the spotlight, but how were the results?

The bulk of the Q1 earnings season is now behind us, with results from more than 460 S&P 500 companies already out. This week, retail took the spotlight, but how were the results?

Defensive Stocks to Consider for a Large Market Correction

Often asked for his economic opinion and outlook, JPMorgan Chase (JPM) CEO Jamie Dimon alluded to concerns of a broader economic slowdown and the possibility of a large stock market correction while speaking with Bloomberg on Thursday.

Often asked for his economic opinion and outlook, JPMorgan Chase (JPM) CEO Jamie Dimon alluded to concerns of a broader economic slowdown and the possibility of a large stock market correction while speaking with Bloomberg on Thursday.

Dividend Watch: 3 Companies Boosting Payouts

Several companies have been delivering positive news to shareholders as of late, including higher dividend payouts. Who doesn't enjoy passive income?

Several companies have been delivering positive news to shareholders as of late, including higher dividend payouts. Who doesn't enjoy passive income?

Top Research Reports for Microsoft, Eli Lilly & Costco

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), Eli Lilly and Co. (LLY) and Costco Wholesale Corp. (COST), as well a micro-cap stock Koss Corp. (KOSS).

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), Eli Lilly and Co. (LLY) and Costco Wholesale Corp. (COST), as well a micro-cap stock Koss Corp. (KOSS).

Bitcoin Breakout: 2 Top Ranked Stocks for the Next Leg Higher

The leading cryptocurrency just broke out from a compelling technical chart pattern. Zacks Strategist Ethan Feller gives us a more complete update.

The leading cryptocurrency just broke out from a compelling technical chart pattern. Zacks Strategist Ethan Feller gives us a more complete update.

5 Stocks Powering the Dow ETF Year to Date

The Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five ETFs that have been leading the way higher this year.

The Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five ETFs that have been leading the way higher this year.

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.

Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.

PFP 5/17: Stocks on Pace for Another Weekly Gain

Relief over largely better than expected inflation numbers this week sent stocks soaring to new all-time highs.

Relief over largely better than expected inflation numbers this week sent stocks soaring to new all-time highs.

Investment Ideas

Stocks

ETFs

ETFs to Play as Mortgage Rates Look Likely to Fall

Mutual Funds

Options

Earnings Analysis

More Analysis

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
CAN 05:31 -0.60 -0.16 +73.33
RBC 08:07 2.32 2.47 +6.47

EPS Positive Surprises for May 17, 2024

Symbol Time Expected Reported %Surprise
THMO 17:31 0.01 -0.46 -4,700.00
AUTL 07:04 -0.10 -0.24 -140.00
HTHT 06:18 0.32 0.29 -9.38

EPS Negative Surprises for May 17, 2024

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
NVDA 2.90% 5.68 5.52
TGT 6.39% 2.18 2.05
LOW 1.60% 2.98 2.94
M 48.57% 0.26 0.18
Trending topics module loader